Delivery Order SPE2DB22D1106-SPE2DB25FFHE0
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,503.23 for Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with a completion date of September 4, 2025. This competitively awarded, non-set-aside delivery order represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's...
- The Defense Logistics Agency awarded a $11,557.43 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Humulin R 500 Unit/mL KwikPen insulin pens (3 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $31,145.42 to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Humulin R 500 Unit/mL KwikPen insulin pens (3mL). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of June 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $6,578.04. This competitively awarded, firm fixed-price delivery order is set to be completed by August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete pharmaceutical procurement under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $21,731.92 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed-price pricing with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location. This delivery order represents a competitive procurement action under the company's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,710.33 for Humulin R 500 unit/mL KwikPen 3mL insulin pens on July 22, 2025, with a completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- The Defense Logistics Agency awarded a $16,119.96 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 8, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $18,663.84 under a firm fixed-price contract type. This non-set-aside award represents a critical pharmaceutical procurement to support federal healthcare operations, with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $9,681.88 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,545.60 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with an ultimate completion date of August 7, 2025. This non-competitive delivery order represents a firm fixed-price pharmaceutical supply transaction to support federal medical procurement needs. The award was issued on August 6, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHE0Delivery Order
The Defense Logistics Agency awarded a $11,542.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of September 8, 2025. This non-set-aside contract represents a small delivery order for pharmaceutical supplies to support military healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and holds an extensive portfolio of federal contracts with DLA and other defense health agencies. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The prime contract encompasses specialty medications, vaccines, generic and brand-name drugs, syringes, vials, and test kits across multiple therapeutic domains, positioning AmerisourceBergen to fulfill critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 9/5/25 |